REN and renovascular hypertension: On the other hand, as the renovascular hypertension model used in our study (2K1C) induces a sustained activation of the renin-angiotensin system (RAS), we chose another classic drug (ENAL) capable of effectively blocking activation and preventing the installation of renovascular hypertension.